Chemoradiation in Elderly Patients with Limited-Stage Small-Cell Lung Cancer

@inproceedings{Tsao2016ChemoradiationIE,
  title={Chemoradiation in Elderly Patients with Limited-Stage Small-Cell Lung Cancer},
  author={Anne S Tsao},
  year={2016}
}
Elderly patients with limited-stage small-cell lung cancer (SCLC) are a challenge to treat due to comorbidities and the required aggressive treatment regimens for curative intent. To determine whether they derive benefit from aggressive therapy, investigators evaluated 8637 stage I–III SCLC patients (median age, 75; year of diagnosis, 2003–2011) in the National Cancer Data Base and evaluated survival outcomes for those treated with chemoradiation (median dose, 59.4 Gy) versus chemotherapy… CONTINUE READING

Topics from this paper.

Similar Papers

Loading similar papers…